Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 11 - Drugs for disorders of the respiratory system
Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767)
04/2003
04/24/2003US20030077734 Isolated human G-protein coupled receptors, nucleic acid molecules encoding human GPCR proteins, and uses thereof
04/24/2003US20030077705 Nucleotide sequences coding polypeptide for use in the treatment of inflammation and ischemia-reperfusion injury
04/24/2003US20030077638 MID 4460, a human tyrosine phosphatase family member and uses therefor
04/24/2003US20030077585 Nucleotide sequences coding polypeptide for use in the diagnosis, detection, prevention and treatment of bacterial infection
04/24/2003US20030077330 Respiratory system disorders; remove carbon dioxide from blood
04/24/2003US20030077322 Solid dispersion system of pranlukast with improved dissolution and method for preparing the same
04/24/2003US20030077291 Active enamel matrix substance, such as an amelogenin, a processed amelogenin product, or a metabolite can be used in treating conditions in a mammal which present an imbalance in its native immune resposne to external or internal stimuli
04/24/2003US20030077275 Chimeric antibody specific to human CD4 which comprises the variable heavy and light chain sequences of an Old World monkey monoclonal antibody produced against human CD4 and human constant heavy and light domain sequences
04/24/2003US20030077271 Use of coagulation factor VII-activating protease for the prophylaxis and therapy of vasoproliferative disorders
04/24/2003US20030077267 Purified forms of DNase
04/24/2003US20030077246 TNFr/OPG-like molecules and uses thereof
04/24/2003US20030075172 Method and apparatus for dispensing inhalator medicament
04/24/2003CA2727642A1 Synthesis of cyclosporin analogs
04/24/2003CA2463991A1 Therapeutic composition and use
04/24/2003CA2463729A1 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors
04/24/2003CA2463628A1 Himbacine analogues as thrombin receptor antagonists
04/24/2003CA2463459A1 Novel use of pulmonary surfactant
04/24/2003CA2463435A1 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma
04/24/2003CA2463159A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
04/24/2003CA2462980A1 Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors
04/24/2003CA2462442A1 Alkyne matrix metalloproteinase inhibitors
04/24/2003CA2462441A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
04/24/2003CA2462147A1 Bicyclic oxopyridine and oxopyrimidine derivatives
04/24/2003CA2461758A1 Use of cystathionine
04/24/2003CA2461542A1 Gap junctions and endothelial-derived hyperpolarizing factor (edhf)
04/24/2003CA2460685A1 Cyclosporine analogue mixtures and their use as immunomodulating agents
04/23/2003EP1304379A2 Humanised antibody against CD18
04/23/2003EP1304322A2 Carboxylic acid compound and use thereof
04/23/2003EP1304118A2 Therapeutic uses and formulations for BPI protein products.
04/23/2003EP1304113A1 Isolated stromal cells and methods of using the same
04/23/2003EP1304112A1 Isolated stromal cells and methods of using the same
04/23/2003EP1304106A1 FREEZE-DRIED PREPARATION OF N- o-(p-PIVALOYLOXYBENZENESULFONYLAMINO)BENZOYL]GLYCINE MONOSODIUM SALT TETRAHYDRATE AND PROCESS FOR PRODUCING THE SAME
04/23/2003EP1304101A1 Composition and method for use of pyridinium derivatives in cosmetic and therapeutic applications
04/23/2003EP1303625A2 Alpha-msh related compounds and methods of use
04/23/2003EP1303620A2 Regulation of human desc1-like serine protease
04/23/2003EP1303619A1 A novel human soluble secreted endopeptidase (sep) for the treatment of sexual dysunfction
04/23/2003EP1303612A2 Streptococcus antigens
04/23/2003EP1303507A1 Pyrimidine derivatives
04/23/2003EP1303506A1 6-heteroarylphenanthridines
04/23/2003EP1303492A2 Aza-bridged-bicyclic amino acid derivatives as alpha 4 integrin antagonists
04/23/2003EP1303490A1 N-oxides as nk1 receptor antagonist prodrugs of 4-phenyl-pyridine derivatives
04/23/2003EP1303488A1 Piperidine compounds for use as ccr-3 inhibitors
04/23/2003EP1303486A1 Pyrrolidine derivatives as metalloprotease inhibitors
04/23/2003EP1303485A1 Pyrrolidine derivatives as inhibitors of endothelin-converting enzyme
04/23/2003EP1303483A1 Novel thiourea derivatives and the pharmaceutical compositions containing the same
04/23/2003EP1303301A2 Preventing airway mucus production by administration of egf-r antagonists
04/23/2003EP1303300A1 Compositions and methods for treatment of candidiasis
04/23/2003EP1303290A1 Small peptides and methods for downregulation of ige
04/23/2003EP1303286A2 Use of strains of the parapox ovis virus for producing antiviral pharmaceuticals and anticancer pharmaceuticals
04/23/2003EP1303281A1 Methods of treatment
04/23/2003EP1303272A2 Benzothiazole derivatives
04/23/2003EP1303258A1 Novel aerosol formulation containing a polar fluorinated molecule
04/23/2003EP1257537A4 Therapeutic morpholino-substituted compounds
04/23/2003EP1250055A4 Immune modulation with death receptor-induced apoptosis
04/23/2003EP1220863B1 Purine derivatives
04/23/2003EP1133483B1 Il-5 inhibiting 6-azauracil derivatives
04/23/2003EP1093450B1 Desformoterol and process for its preparation
04/23/2003EP1045851B1 Substituted porphyrins
04/23/2003EP1045690B1 Benzenesulfonamide inhibitors of pde-iv and their therapeutic use
04/23/2003EP1035848B1 Substituted alkanohydroxamic acids and method of reducing tnf-alpha levels
04/23/2003EP0937041B1 Use of a pharmaceutically acceptable salt of (3R,2'R)-3-[(Cyclopently-hydroxyphenylacetyl)oxy]-1,1-dimethyl-pyrrolidinium for the preparation of a medicament
04/23/2003CN1413251A Novel endoplasmic reticulum-localized protein, remedies containing the same for diseases associated with glycoprotein abnormality, DNA encoding this protein and gene remedies containing the same
04/23/2003CN1413250A Method of producing differentiated progenitor cells and lineage-defective embryonic stem cells
04/23/2003CN1413213A Azaindoles
04/23/2003CN1413211A Substituted 1,3,4-oxadiazoles and method of producing TNF-alpha levels
04/23/2003CN1413210A Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
04/23/2003CN1413207A 5-membered ring heterocyclic compounds with nitrogen
04/23/2003CN1413206A Non peptide tachykinin receptor antagonists
04/23/2003CN1413196A 2-Arylquinoline derivatives, preparation and therapeutic use thereof
04/23/2003CN1413193A Nitrile derivatives as cathepsin K inhibitors
04/23/2003CN1413192A Substituted indole mannich bases
04/23/2003CN1413186A Aminobenzophenones as inhibitors of IL-1 beta and TNF-alpha
04/23/2003CN1413185A Substitued 1 and 2 naphthol mannich bases
04/23/2003CN1413112A Nasal drops containing fused pyridazine derivatives
04/23/2003CN1413109A Substituted acylhydroxamic acids and method of reducing TNF-alpha levels
04/23/2003CN1413105A Novel method of treatment
04/23/2003CN1413104A New (aminopropyl) methylphosphinic acids
04/23/2003CN1412181A Carboxylic acid derivative capable of inhibiting combination of integrin and its receptor
04/23/2003CN1411859A Chinese medicine plaster for curing diseases of digestive, respiratory and circulatory systems and its preparation process
04/23/2003CN1411809A Usage and composition of pyridine onium derivative for curing application
04/23/2003CN1411806A Bromhexine hydrochloride injection and its preparation method
04/23/2003CN1411800A Cosmetic composition and method
04/23/2003CN1106390C Tachykinin receptor antagonist substituted methyl keto-morpholine crystal form
04/23/2003CN1106387C PDEIV inhibiting 2-cyanoiminoimidazole derivatives
04/23/2003CN1106384C Indoline-2-one derivatives, its preparing method and its medicinal compositions
04/23/2003CA2403307A1 Substituted 2-cyclohexyl-4-phenyl-1h-imidazole derivatives
04/22/2003US6552216 Molecular model for VLA-4 inhibitors
04/22/2003US6552202 Crystal form of N-(4-trifluoromethylphenyl)-5-methylisoxazole-4-carboxamide
04/22/2003US6552200 Intermediates useful for the preparation of antihistaminic piperidine derivatives
04/22/2003US6552188 Unsymmetrical cyclic diamine compound
04/22/2003US6552088 Biphenyl derivatives
04/22/2003US6552081 Methods for treating disorders in which docosahexaenoic acid (DHA) levels are affected
04/22/2003US6552051 Useful as high energy oxidizing agents in explosive and propellant formulations, and drugs for vasodilation
04/22/2003US6552036 3-(Diarylmethylene)-8-azabicyclo[3.2.1]octane derivatives
04/22/2003US6552029 For therapy of rheumatoid arthritis, psoriasis, graft v. host disease, asthma, atopic dermatitis, allergic rhinitis, allergic conjunctivitis, complications following percutaneous transluminal coronary angioplasty, thrombosis
04/22/2003US6552028 Inhibiting the binding of eotaxin to chemokine-3 (ccr-3) receptor; antiasthmatics
04/22/2003US6552019 Inhibitors of p38
04/22/2003US6551989 Preventing airway mucus production by administration of EGF-R antagonists
04/22/2003US6551626 Composition containing pyrrolizidine-alkaloid-free petasites
04/22/2003US6550474 Microencapsulated fragrances and methods of coating microcapsules
1 ... 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 ... 878